GAST and colonic neoplasm: Recently, ANXA2 is identified as a novel receptor for gastrin and progastrin (PG) peptides, which mediate the growth stimulatory effects of autocrine and exogenous gastrin and PG peptides on intestinal epithelial and colon cancer cells [77].